glp-1 drug market size Size, Scope, Forecast Report 2026 to 2035 GLP-1 Receptor Agonist Market Growth

Accessed at pubmed.ncbi.nlm.nih.gov/21844879

The above is only a summary

Conversely, economic downturns can lead to budgetary constraints in healthcare systems and potentially limit patient access, especially in countries with less robust reimbursement mechanisms

Excess food intake or rapid gastric emptying that exceeds the absorptive capacity of the upper small intestine increases the amount of unabsorbed nutrients in the lumen of the more distally located small intestine, thereby increasing the amount of GLP-1 secretion

FIGURE 1 Currently, two main classes of GLP-1 RAs are available (Mller et al., 2019

The effects of dual GLP-1/GIP receptor agonism on glucagon secretion: a review